CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
August 2014—Curetis announced that Robin Patel, MD, professor of medicine and microbiology at Mayo Clinic in Rochester, Minn., has been named lead principal investigator of the company’s Unyvero LRT Application FDA trial. The lower respiratory tract application is designed to detect 17 pathogens and 22 antibiotic-resistance gene markers of clinical importance in patients with suspected LRT infections.
The company also announced the addition of six new clinical trial sites, expanding its clinical trial network to nine high-profile testing sites.
Curetis, 49 (0)7031 49195-10